In-Vivo Toxicology Market - Global Industry Analysis

In-Vivo Toxicology Market By Product Types(Instruments, Animal Models, and Reagents & Kits), By Testing Types (Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), By Toxicity Endpoints (Immunotoxicity, Systemic), By Testing Facility (Outsourced, In-House), By End-User (Academic Institutes, Research Institutes, and CRO’s) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 27-Jun-2022 Category: Pharmaceutical Report Format : PDF Pages: 222 Report Code: ZMR-965 Status : Published

The global in-vivo toxicology market grasped a revenue growth of USD 5.23 billion in 2021 and is projected to grow to around USD 7.54 billion by 2028 at a CAGR rate of 6.3 percent over the forecast period.

Description

Industry Prospective:

The global in-vivo toxicology market was worth around $ 5.23 billion in 2021 and is predicted to grow to around $ 7.54 billion by 2028 at a CAGR rate of 6.3% over the forecast period. In this report, we will cover the full overview, growth drivers, opportunities, and obstacles of the in-vivo toxicology market.

In-Vivo Toxicology Market: Overview

The toxic effect of chemicals is examined on non-human living organisms which are basically called as In-Vivo Toxicology. The cytotoxicity tests actually expose the adverse effects of the drug in living organisms. Before it could be tested on humans, it is tested on organisms or animals to identify the effect of a drug. Many animals are used for testing such as guinea pigs, rodents, rabbits, and others. They are also injected by different ways of exposure. The prominent ones are intravenous, topical, intramuscular, and others.

These tests are done on the isolated organs or parts of the animals. Most hazardous chemical substances actually go through validation in this process even during the early stages of the drug development. The safety evaluation of the drug along with its ranking as a potential drug is done through in-vivo toxicology testing. It includes a total evaluation of all the responses put together like absorption, distribution, metabolism, excretion, dose-response, and threshold response of the drug. Various industries use them on a frequent basis like pharmaceuticals, chemicals, and the food industry. Many research and development organizations also use these kinds of tests on the organisms on a regular basis.

These tests also have the capacity to expose the presence of cultured bacteria or any alien infections in the body. Sometimes, not just the harmful effects of drugs are being exposed, but also the deficiency or toxic properties infested in the organism are identified. The resultant product could be anything ranging from treatment drugs to any agricultural chemicals or even general food additives.

Global In Vivo Toxicology Testing Market

In-Vivo Toxicology Market: Growth Drivers

Recent innovations in pharmaceutical and biotechnology industries along with rising focus on personalized medications to propel the market growth

Recent innovations in human cell culture, as well as test systems, instigates an expansion of the market. These tests are predictive, demonstrative, and extremely suitable for screening nanomaterials and airborne materials which makes them a leveraging aspect of drug validation for the companies.

The pharmaceutical and biotechnology industries are keen on developing drug products that have real value rather than some immediate benefits. Hence many innovations in testing methods have been on the rise and serious validation based on its real outcome has been deemed important. This increases the demand for in-vivo toxicology testing in all medical industries thereby propelling market growth considerably.

The focus on bringing the attrition rate of failing molecules in the early stages has become more significant and there is a considerable increase in the leverage of in-vivo testing. An increase in the innovations of animal model testing coupled with rising in the focus on personalized medications also triggers market growth.

There is also an eminent increase in clinical trials which contributes to the growth of the global in-vivo toxicology market. Oncology research along with humanized animal models testing has gained traction which is fueling the market growth in huge proportions. The increase in funding of small biotech firms and small-scale start-ups in pharmaceutical sectors induce market growth as well.

There has also been a considerable rise in the development of toxic substances and dosage testing which has increased the demand for in-vivo testing. Apart from this, this testing has been adopted in various sectors such as pharmaceutical, chemicals, biotechnology firms, cosmetics, and household products.

Covid-19 Impact

Covid-19 had a neutral and mediocre effect on the in-vivo toxicology market. Many research operations and manufacturing operations were halted due to the lack of manpower and government regulations or protocols for pandemics. No new innovations or consignments happened in the biomedical sector which impacted the market exclusively. However, the unprecedented health challenge and the focus on vaccine development increased the demand for animal-model testing. The mice-model testing especially ACE2 humanized mice was leveraged more for SARS-CoV infection and the development of vaccinations for it. Governments and scientific research institutions are also bound to increase research investments in treatments and vaccines using in-vivo testing which boosts market growth promptly.

In-Vivo Toxicology Market: Restraints

Availability of alternate methods of testing to animal testing and growing contempt against animal testing hampers the market growth

Animal welfare communities have increased the pressure of contention against animal testing. This has triggered the research scientists and toxicology experts to come up with new methods of alternative testing methods. This impedes market growth to a large extent. In-vitro testing as an alternative has been blooming in recent times and many mainstream companies have adopted that testing method to reduce animal use in toxicology studies. This factor invariably limits the demand for animal model testing proportionally.

In-Vivo Toxicology Market: Opportunities

The increasing trend of humanized animal model testing in preclinical research provides a lucrative opportunity for market growth

Humanized animal models gained from human cells or tissues have been used rapidly in biotechnology firms. The actual effects of drugs on humans are being estimated by this method which is also deemed to be more precise than any other testing method. They also expose any kind of human-specific infections, and therapies that cure them as well. This factor actually increases the demand and leverage of in-vivo toxicology testing. An increase in oncology research and focus on personalized medicines provide opportunities for the global in-vivo toxicology market expansion.

In-Vivo Toxicology Market: Challenges

Government regulations against harming animals for medical testing pose a challenge for the market growth

There has been an increase in the regulations and laws regarding the ethical use of animals in research which instigates the scientists to look for alternative methods of testing. There are also loopholes in animal testing which affect the accuracy and efficacy of the results. All these factors pose a challenge to market growth.

Chronic test type segment in in-vivo testing has increased because of the growing chronic diseases which pose a challenge for the market

In-vivo toxicology is segmented as acute, sub-acute, sub-chronic test types. This has been used rapidly because of the increasing spread of chronic diseases in the geriatric population. This has increased the leverage and demand for in-vivo testing which triggers large-scale employment of the testing equipment and faculties. This poses a challenge for the market to satisfy this massive demand for in-vivo testing.

In-Vivo Toxicology Market: Segmentation

The global In-vivo toxicology in this research analysis is divided into product types, testing types, toxicity endpoints, testing facilities, end-user, and regions. The product types are classified as instruments, animal models, and reagents & kits. The testing types are divided into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. The toxicity endpoints are immunotoxicity and systemic. The testing facilities are outsourced and in-house. End-users comprise academic institutes, research institutes, and CROs.

Recent Developments:

  • In March 2020, GenOway acquired exclusive worldwide rights from Merck for its foundational CRISPR/Cas9 portfolio in the rodent field.
  • In July 2020, Taconic entered into an agreement with the University of Texas Medical Branch to distribute humanized ACE2 mice for COVID-19 research.
  • In December 2020, the Jackson Laboratory started the production of ACE2 mice to support the research on COVID-19.

Regional Landscape:

North America is the largest share of the global in-vivo toxicology market. This is due to the presence of major players in the in-vivo toxicology market. There is a growing trend of biomedical research and preclinical activities by CROs happening in this region which makes it the most dominating region for the in-vivo toxicology market. Asia Pacific region also trails as the second-largest share of the market due to the significant growth opportunities for pharmaceutical firms in this region. The growing geriatric population along with qualified researchers and low-cost operations in this region are supporting factors of market growth.

Competitive Landscape:

The key players in the global in-vivo toxicology market are Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Janvier Labs, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, MerckkgaA, GE Healthcare, Bio-Rad laboratories, genOway, Cyagen Biosciences, GVK BIO, Polygene, Crown Biosciences, Transcure Bioservices, and Harbour BioMed.  

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global in-vivo toxicology market segmentation follows

By Product Type

  • Instruments
  • Animal Models
  • Reagents & Kits

By Testing Types

  • Chronic Toxicity Testing
  • Sub-Chronic Toxicity Testing
  • Sub-acute Toxicity Testing
  • Acute Toxicity Testing

By Toxicity Endpoints

  • Immunotoxicity
  • Systemic

By Testing facility

  • Outsourced
  • In-house

By End-user

  • Academic Institutes
  • Research Institutes
  • CRO’s

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global In-Vivo Toxicology Market, (2022 - 2028) (USD Billion)
    • 2.2 Global In-Vivo Toxicology Market : snapshot
  • Chapter 3. Global In-Vivo Toxicology Market - Industry Analysis
    • 3.1 In-Vivo Toxicology Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Recent innovations in pharmaceutical and biotechnology industries along with rising focus on personalized medications to propel the market growth
    • 3.3 Market Restraints
      • 3.3.1. Availability of alternate methods of testing to animal testing and growing contempt against animal testing hampers the market growth
    • 3.4 Market Opportunities
      • 3.4.1. The increasing trend of humanized animal model testing in preclinical research provides a lucrative opportunity for market growth
    • 3.5 Market Challenges
      • 3.5.1. Government regulations against harming animals for medical testing pose a challenge for the market growth
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product Type
      • 3.7.2 Market attractiveness analysis By Testing Types
      • 3.7.3 Market attractiveness analysis By Toxicity Endpoints
      • 3.7.4 Market attractiveness analysis By Testing facility
      • 3.7.5 Market attractiveness analysis By End-user
  • Chapter 4. Global In-Vivo Toxicology Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global In-Vivo Toxicology Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global In-Vivo Toxicology Market - Product Type Analysis
    • 5.1 Global In-Vivo Toxicology Market overview: By Product Type
      • 5.1.1 Global In-Vivo Toxicology Market share, By Product Type, 2021 and 2028
    • 5.2 Instruments
      • 5.2.1 Global In-Vivo Toxicology Market by Instruments, 2022 - 2028 (USD Billion)
    • 5.3 Animal Models
      • 5.3.1 Global In-Vivo Toxicology Market by Animal Models, 2022 - 2028 (USD Billion)
    • 5.4 Reagents & Kits
      • 5.4.1 Global In-Vivo Toxicology Market by Reagents & Kits, 2022 - 2028 (USD Billion)
  • Chapter 6. Global In-Vivo Toxicology Market - Testing Types Analysis
    • 6.1 Global In-Vivo Toxicology Market overview: By Testing Types
      • 6.1.1 Global In-Vivo Toxicology Market share, By Testing Types, 2021 and 2028
    • 6.2 Chronic Toxicity Testing
      • 6.2.1 Global In-Vivo Toxicology Market by Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
    • 6.3 Sub-Chronic Toxicity Testing
      • 6.3.1 Global In-Vivo Toxicology Market by Sub-Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
    • 6.4 Sub-acute Toxicity Testing
      • 6.4.1 Global In-Vivo Toxicology Market by Sub-acute Toxicity Testing, 2022 - 2028 (USD Billion)
    • 6.5 Acute Toxicity Testing
      • 6.5.1 Global In-Vivo Toxicology Market by Acute Toxicity Testing, 2022 - 2028 (USD Billion)
  • Chapter 7. Global In-Vivo Toxicology Market - Toxicity Endpoints Analysis
    • 7.1 Global In-Vivo Toxicology Market overview: By Toxicity Endpoints
      • 7.1.1 Global In-Vivo Toxicology Market share, By Toxicity Endpoints, 2021 and 2028
    • 7.2 Immunotoxicity
      • 7.2.1 Global In-Vivo Toxicology Market by Immunotoxicity, 2022 - 2028 (USD Billion)
    • 7.3 Systemic
      • 7.3.1 Global In-Vivo Toxicology Market by Systemic, 2022 - 2028 (USD Billion)
  • Chapter 8. Global In-Vivo Toxicology Market - Testing facility Analysis
    • 8.1 Global In-Vivo Toxicology Market overview: By Testing facility
      • 8.1.1 Global In-Vivo Toxicology Market share, By Testing facility, 2021 and 2028
    • 8.2 Outsourced
      • 8.2.1 Global In-Vivo Toxicology Market by Outsourced, 2022 - 2028 (USD Billion)
    • 8.3 In-house
      • 8.3.1 Global In-Vivo Toxicology Market by In-house, 2022 - 2028 (USD Billion)
  • Chapter 9. Global In-Vivo Toxicology Market - End-user Analysis
    • 9.1 Global In-Vivo Toxicology Market overview: By End-user
      • 9.1.1 Global In-Vivo Toxicology Market share, By End-user, 2021 and 2028
    • 9.2 Academic Institutes
      • 9.2.1 Global In-Vivo Toxicology Market by Academic Institutes, 2022 - 2028 (USD Billion)
    • 9.3 Research Institutes
      • 9.3.1 Global In-Vivo Toxicology Market by Research Institutes, 2022 - 2028 (USD Billion)
    • 9.4 CRO’s
      • 9.4.1 Global In-Vivo Toxicology Market by CRO’s, 2022 - 2028 (USD Billion)
  • Chapter 10. In-Vivo Toxicology Market - Regional Analysis
    • 10.1 Global In-Vivo Toxicology Market Regional Overview
    • 10.2 Global In-Vivo Toxicology Market Share, by Region, 2021 & 2028 (USD Billion)
    • 10.3. North America
      • 10.3.1 North America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
        • 10.3.1.1 North America In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 North America In-Vivo Toxicology Market, by Product Type, 2022 - 2028
      • 10.4.1 North America In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.5 North America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
      • 10.5.1 North America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
    • 10.6 North America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
      • 10.6.1 North America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
    • 10.7 North America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
      • 10.7.1 North America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
    • 10.8 North America In-Vivo Toxicology Market, by End-user, 2022 - 2028
      • 10.8.1 North America In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
    • 10.4. Europe
      • 10.4.2 Europe In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
        • 10.4.2.1 Europe In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 Europe In-Vivo Toxicology Market, by Product Type, 2022 - 2028
      • 10.4.1 Europe In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.5 Europe In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
      • 10.5.1 Europe In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
    • 10.6 Europe In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
      • 10.6.1 Europe In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
    • 10.7 Europe In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
      • 10.7.1 Europe In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
    • 10.8 Europe In-Vivo Toxicology Market, by End-user, 2022 - 2028
      • 10.8.1 Europe In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
    • 10.5. Asia Pacific
      • 10.5.3 Asia Pacific In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
        • 10.5.3.1 Asia Pacific In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 Asia Pacific In-Vivo Toxicology Market, by Product Type, 2022 - 2028
      • 10.4.1 Asia Pacific In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.5 Asia Pacific In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
      • 10.5.1 Asia Pacific In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
    • 10.6 Asia Pacific In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
      • 10.6.1 Asia Pacific In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
    • 10.7 Asia Pacific In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
      • 10.7.1 Asia Pacific In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
    • 10.8 Asia Pacific In-Vivo Toxicology Market, by End-user, 2022 - 2028
      • 10.8.1 Asia Pacific In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
    • 10.6. Latin America
      • 10.6.4 Latin America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
        • 10.6.4.1 Latin America In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 Latin America In-Vivo Toxicology Market, by Product Type, 2022 - 2028
      • 10.4.1 Latin America In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.5 Latin America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
      • 10.5.1 Latin America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
    • 10.6 Latin America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
      • 10.6.1 Latin America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
    • 10.7 Latin America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
      • 10.7.1 Latin America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
    • 10.8 Latin America In-Vivo Toxicology Market, by End-user, 2022 - 2028
      • 10.8.1 Latin America In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
    • 10.7. The Middle-East and Africa
      • 10.7.5 The Middle-East and Africa In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
        • 10.7.5.1 The Middle-East and Africa In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 The Middle-East and Africa In-Vivo Toxicology Market, by Product Type, 2022 - 2028
      • 10.4.1 The Middle-East and Africa In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.5 The Middle-East and Africa In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
      • 10.5.1 The Middle-East and Africa In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
    • 10.6 The Middle-East and Africa In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
      • 10.6.1 The Middle-East and Africa In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
    • 10.7 The Middle-East and Africa In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
      • 10.7.1 The Middle-East and Africa In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
    • 10.8 The Middle-East and Africa In-Vivo Toxicology Market, by End-user, 2022 - 2028
      • 10.8.1 The Middle-East and Africa In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
  • Chapter 11. Company Profiles
    • 11.1 Charles River Laboratories
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 The Jackson Laboratory
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 Envigo
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Taconic Biosciences
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 Janvier Labs
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 Thermo Fisher Scientific
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 Danaher Corporation
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 Waters Corporation
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 Agilent Technologies
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 Shimadzu Corporation
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments
    • 11.11 Bruker Corporation
      • 11.11.1 Overview
      • 11.11.2 Financials
      • 11.11.3 Product Portfolio
      • 11.11.4 Business Strategy
      • 11.11.5 Recent Developments
    • 11.12 PerkinElmer
      • 11.12.1 Overview
      • 11.12.2 Financials
      • 11.12.3 Product Portfolio
      • 11.12.4 Business Strategy
      • 11.12.5 Recent Developments
    • 11.13 MerckkgaA
      • 11.13.1 Overview
      • 11.13.2 Financials
      • 11.13.3 Product Portfolio
      • 11.13.4 Business Strategy
      • 11.13.5 Recent Developments
    • 11.14 GE Healthcare
      • 11.14.1 Overview
      • 11.14.2 Financials
      • 11.14.3 Product Portfolio
      • 11.14.4 Business Strategy
      • 11.14.5 Recent Developments
    • 11.15 Bio-Rad laboratories
      • 11.15.1 Overview
      • 11.15.2 Financials
      • 11.15.3 Product Portfolio
      • 11.15.4 Business Strategy
      • 11.15.5 Recent Developments
    • 11.16 genOway
      • 11.16.1 Overview
      • 11.16.2 Financials
      • 11.16.3 Product Portfolio
      • 11.16.4 Business Strategy
      • 11.16.5 Recent Developments
    • 11.17 Cyagen Biosciences
      • 11.17.1 Overview
      • 11.17.2 Financials
      • 11.17.3 Product Portfolio
      • 11.17.4 Business Strategy
      • 11.17.5 Recent Developments
    • 11.18 GVK BIO
      • 11.18.1 Overview
      • 11.18.2 Financials
      • 11.18.3 Product Portfolio
      • 11.18.4 Business Strategy
      • 11.18.5 Recent Developments
    • 11.19 Polygene
      • 11.19.1 Overview
      • 11.19.2 Financials
      • 11.19.3 Product Portfolio
      • 11.19.4 Business Strategy
      • 11.19.5 Recent Developments
    • 11.20 Crown Biosciences
      • 11.20.1 Overview
      • 11.20.2 Financials
      • 11.20.3 Product Portfolio
      • 11.20.4 Business Strategy
      • 11.20.5 Recent Developments
    • 11.21 Transcure Bioservices
      • 11.21.1 Overview
      • 11.21.2 Financials
      • 11.21.3 Product Portfolio
      • 11.21.4 Business Strategy
      • 11.21.5 Recent Developments
    • 11.22 Harbour BioMed.
      • 11.22.1 Overview
      • 11.22.2 Financials
      • 11.22.3 Product Portfolio
      • 11.22.4 Business Strategy
      • 11.22.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global In-Vivo Toxicology Market attractiveness, By Product Type
  • 6. Global In-Vivo Toxicology Market attractiveness, By Testing Types
  • 7. Global In-Vivo Toxicology Market attractiveness, By Toxicity Endpoints
  • 8. Global In-Vivo Toxicology Market attractiveness, By Testing facility
  • 9. Global In-Vivo Toxicology Market attractiveness, By End-user
  • 10. Global In-Vivo Toxicology Market share by Product Type, 2022 and 2028 (USD Billion)
  • 11. Global In-Vivo Toxicology Market by Instruments, 2022 - 2028 (USD Billion)
  • 12. Global In-Vivo Toxicology Market by Animal Models, 2022 - 2028 (USD Billion)
  • 13. Global In-Vivo Toxicology Market by Reagents & Kits, 2022 - 2028 (USD Billion)
  • 14. Global In-Vivo Toxicology Market share by Testing Types, 2022 and 2028 (USD Billion)
  • 15. Global In-Vivo Toxicology Market by Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
  • 16. Global In-Vivo Toxicology Market by Sub-Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
  • 17. Global In-Vivo Toxicology Market by Sub-acute Toxicity Testing, 2022 - 2028 (USD Billion)
  • 18. Global In-Vivo Toxicology Market by Acute Toxicity Testing, 2022 - 2028 (USD Billion)
  • 19. Global In-Vivo Toxicology Market share by Toxicity Endpoints, 2022 and 2028 (USD Billion)
  • 20. Global In-Vivo Toxicology Market by Immunotoxicity, 2022 - 2028 (USD Billion)
  • 21. Global In-Vivo Toxicology Market by Systemic, 2022 - 2028 (USD Billion)
  • 22. Global In-Vivo Toxicology Market share by Testing facility, 2022 and 2028 (USD Billion)
  • 23. Global In-Vivo Toxicology Market by Outsourced, 2022 - 2028 (USD Billion)
  • 24. Global In-Vivo Toxicology Market by In-house, 2022 - 2028 (USD Billion)
  • 25. Global In-Vivo Toxicology Market share by End-user, 2022 and 2028 (USD Billion)
  • 26. Global In-Vivo Toxicology Market by Academic Institutes, 2022 - 2028 (USD Billion)
  • 27. Global In-Vivo Toxicology Market by Research Institutes, 2022 - 2028 (USD Billion)
  • 28. Global In-Vivo Toxicology Market by CRO’s, 2022 - 2028 (USD Billion)
  • 29. Global In-Vivo Toxicology Market share, by Region, 2022 and 2028
  • 30. North America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
  • 31. Europe In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
  • 32. Asia Pacific In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
  • 33. Latin America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
  • 34. The Middle-East and Africa In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global In-Vivo Toxicology Market: Snapshot
  • 2. Drivers of the In-Vivo Toxicology Market: impact analysis
  • 3. North America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 4. North America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 5. North America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 6. North America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 7. North America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 8. U.S. In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 9. U.S. In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 10. U.S. In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 11. U.S. In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 12. U.S. In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 13. Canada In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 14. Canada In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 15. Canada In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 16. Canada In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 17. Canada In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 18. Europe In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 19. Europe In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 20. Europe In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 21. Europe In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 22. Europe In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 23. Germany In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 24. Germany In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 25. Germany In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 26. Germany In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 27. Germany In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 28. France In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 29. France In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 30. France In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 31. France In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 32. France In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 33. U.K. In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 34. U.K. In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 35. U.K. In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 36. U.K. In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 37. U.K. In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 38. Italy In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 39. Italy In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 40. Italy In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 41. Italy In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 42. Italy In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 43. Spain In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 44. Spain In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 45. Spain In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 46. Spain In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 47. Spain In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 48. Rest of Europe In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 49. Rest of Europe In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 50. Rest of Europe In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 51. Rest of Europe In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 52. Rest of Europe In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 53. Asia Pacific In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 54. Asia Pacific In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 55. Asia Pacific In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 56. Asia Pacific In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 57. Asia Pacific In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 58. China In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 59. China In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 60. China In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 61. China In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 62. China In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 63. Japan In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 64. Japan In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 65. Japan In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 66. Japan In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 67. Japan In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 68. India In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 69. India In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 70. India In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 71. India In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 72. India In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 73. South Korea In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 74. South Korea In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 75. South Korea In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 76. South Korea In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 77. South Korea In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 78. South-East Asia In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 79. South-East Asia In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 80. South-East Asia In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 81. South-East Asia In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 82. South-East Asia In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 83. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 84. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 85. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 86. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 87. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 88. Latin America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 89. Latin America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 90. Latin America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 91. Latin America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 92. Latin America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 93. Brazil In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 94. Brazil In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 95. Brazil In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 96. Brazil In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 97. Brazil In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 98. Mexico In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 99. Mexico In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 100. Mexico In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 101. Mexico In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 102. Mexico In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 103. Rest of Latin America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 104. Rest of Latin America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 105. Rest of Latin America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 106. Rest of Latin America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 107. Rest of Latin America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 108. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 109. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 110. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 111. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 112. The Middle-East and Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 113. GCC Countries In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 114. GCC Countries In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 115. GCC Countries In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 116. GCC Countries In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 117. GCC Countries In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 118. South Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 119. South Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 120. South Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 121. South Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 122. South Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
  • 123. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 124. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
  • 125. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
  • 126. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
  • 127. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)

Methodology

Choose License Type

FrequentlyAsked Questions

Recent innovations in pharmaceutical and biotechnology industries along with a rising focus on personalized medications propel market growth

According to the report by Zion Market Research, The global In-Vivo toxicology market was worth around $ 5.23 billion in 2021 and is predicted to grow to around $ 7.54 billion by 2028 at a CAGR rate of 6.3% over the forecast period

North America is the largest share of the in-vivo toxicology market. This is due to the presence of major players in the in-vivo toxicology market. There is a growing trend of biomedical research and preclinical activities by CROs happening in this region which makes it the most dominating region for the in-vivo toxicology market.

The key players in the global in-vivo toxicology market are Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Janvier Labs, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, MerckkgaA, GE Healthcare, Bio-Rad laboratories, genOway, Cyagen Biosciences, GVK BIO, Polygene, Crown Biosciences, Transcure Bioservices, and Harbour BioMed.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed